• SW Design

    Biomedical R&D

    Covering the whole value chain of pharmaceutical R&D

    VectorB2B is your partner for cost-efficient, rapid, and tailored-made solutions every-step-of-the-way in drug discovery & development
  • SW Design

    CMC

    Seamless process development from lab to GMP

    Our specialists develop the best process for your needs, including galenic formulation and biologic cultures – from lab scale to bioreactor.
  • SW Design

    COVID-19

    Accelerate SARS-CoV-2 therapeutic, vaccine or test development

    Let us support you in the fight against COVID-19 with our antibody development services and our clinical trial expertise.

Driving force in drug development

Portugal’s best teams in science and clinics have joined forces to provide cutting-edge, customized solutions in drug development for academia and industry

Hear from our Clients

Atreca logo no background

Daniel Emerling
SVP Research, Atreca, Inc.

“Working with Vector B2B not only provided us with great data and thorough reports regarding the experiments we requested, but their scientific expertise helped optimize and improve the design of our experiments and success of our project. I definitely recommend engaging VectorB2B

“AFFIX Labs is a fast moving chemical technology company that is in need of partners that can keep up with our needs. VectorB2B has proven to be a flexible partner that is willing to go beyond the expected service level. During the start of the Corona pandemic VectorB2B was able to support our company in proving that our anti-viral coating was effective against the pathogen that causes COVID-19, they were able to overcome challenges in an excellent manner and kept up with proper communications doing so.
We expect to work on more projects in the near future”.

Tom Sam
CEO AFFIX Labs

Tell us how we can help you

Previous Work

Ask one of our Specialist

Applying CellectAB technology to generate antibodies against CD3

Alginate Hydrogels for Medical Applications

Developing a xenograft mouse model of canine diffuse large B-cell lymphoma (DLBCL)

Process Developement of Bacteriophages for

Assay development for the evaluationof antiviral COVID-19 surface coatings

Investigating the potential of new therapeutic strategies relevant for the treatment of glaucoma

associate members

news & announcements

contact us

Vector B2B

Drug Developing – Associação para Investigação em Biotecnologia

Address
Avenida Professor Gama Pinto nº.2

Alameda da Universidade,
Cidade Universitária

1649-003 Lisboa

E-mail
info@vectorb2b.com

Google Maps

By loading the map, you agree to Google's privacy policy.
Learn more

Load map